Vancouver, British Columbia – December 18, 2019 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform designed to restore innate immune function, is… Read More
SEATTLE, Dec. 20, 2019 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq: NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the closing of its public offering of 10,263,750… Read More
January 3rd, 2020 | Uncategorized Technology startup company in need of professional office space? The Generator Challenge awards free furnished office space for 12 months to startups deemed most-likely to succeed… Read More
WAT Medical is a Canadian company that develops safe, effective, and user-friendly wearable medical devices. They focus on chronic and functional diseases and conditions. Their technologies use targeted neuromodulation to… Read More
SEATTLE, Dec. 17, 2019 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that it intends to offer and sell, subject to… Read More
